Newsroom

Newsroom

PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer

Literature
Read More

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Literature
Read More

Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome

Literature
Read More

Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism

Literature
Read More

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

Press Release
Read More

Detection of IFNγ induced PD-L1 expression by combined in situ RNA analysis and protein profiling from a single FFPE slide

Literature
Read More

MultiOmyx™ multiplexed tumor infiltrating lymphocyte panel provides comprehensive immunophenotyping from a single FFPE slide

Literature
Read More

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients